Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

G3SB67 (G3SB67_GORGO) Gorilla gorilla gorilla (Western lowland gorilla)

glutaminase UniProtKBInterProSTRINGInteractive Modelling

669 aa; Sequence (Fasta) ; 2 identical sequences: Homo sapiens: O94925; Pan troglodytes: H2QJ59

Available Structures

47 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Multidomain structure of human kidney-type glutaminase(KGA/GLS) Heteromer
O94925;
137-643
04A;
Assess
Human glutaminase C (Y466W) with L-Gln and Pi, filamentous formhomo-12-mer139-525
12×PO4; 12×GLN;
Assess
Crystal Structure of Human GAC in Complex with Glutamate and BPTEShomo-4-mer136-560
GOL;04A;
Assess
Human glutaminase C (Y466W) with L-Gln, closed conformationhomo-4-mer134-546
GLN;
Assess
Crystal Structure of Human GAC in Complex with Glutamatehomo-4-mer135-546
GLU;
Assess
Human GLS in complex with compound 12homo-4-mer136-546
R90;
Assess
Crystal structure of glutaminase C in complex with inhibitor CB-839homo-4-mer137-546
63J;
Assess
Crystal structure of human GAC in complex with inhibitor UPGL00023homo-4-mer137-546
Q9M;
Assess
Crystal structure of human GAC in complex with inhibitor UPGL_00009: 2-phenyl-~{N}-[5-[[(3~{R})-1-[…homo-4-mer137-546
5XX;
Assess
Crystal structure of human GAC in complex with inhibitor UPGL00013homo-4-mer137-546
Q94;
Assess
Crystal structure of human GAC in complex with inhibitor UPGL_00015: 2-phenyl-~{N}-[5-[(3~{S})-3-[[…homo-4-mer137-546
5XZ;
Assess
Crystal structure of human GAC in complex with inhibitor UPGL_00011: 2-phenyl-~{N}-[5-[[(3~{S})-1-[…homo-4-mer137-546
5XY;
Assess
Crystal structure of human GAC in complex with inhibitor UPGL00012homo-4-mer137-546
QAM;
Assess
Crystal structure of human GAC in complex with inhibitor UPGL00012homo-4-mer137-546
QAA;
Assess
Crystal structure of human GAC in complex with inhibitor UPGL00012homo-4-mer137-546
QAJ;
Assess
Crystal structure of human GAC in complex with inhibitor UPGL00012homo-4-mer137-546
U27;
Assess
Room temperature serial crystal structure of Glutaminase C in complex with inhibitor UPGL-00004homo-4-mer137-546
B4A;
Assess
Human glutaminase C (Y466W) with L-Gln, open conformationhomo-4-mer137-546
GLN;
Assess
Crystal structure of human GAC in complex with inhibitor UPGL00018homo-4-mer137-546
Q9S;
Assess
Crystal structure of human GAC in complex with inhibitor UPGL00012homo-4-mer137-546
QAJ;
Assess
Crystal structure of human GAC in complex with inhibitor UPGL00012homo-4-mer137-546
QA4;
Assess
Crystal structure of human glutaminase C in complex with the inhibitor UPGL-00019homo-4-mer137-546
69V;
Assess
Crystal structure of human GAC in complex with inhibitor UPGL00012homo-4-mer137-546
Q9V;
Assess
Crystal structure of human GAC in complex with inhibitor UPGL00012homo-4-mer137-546
Q9A;
Assess
Crystal Structure of human glutaminase with macrocyclic inhibitorhomo-4-mer137-546
EN3;
Assess
Crystal structure of full length human glutaminase C expressed in E.colihomo-4-mer138-546
Assess
Room temperature serial crystal structure of Glutaminase C in complex with inhibitor BPTEShomo-4-mer137-545
04A;
Assess
Crystal structure of glutaminase C in complex with compound 27homo-4-mer138-545
V4I;
Assess
Crystal structure of glutaminase C in complex with compound 11homo-4-mer138-544
V59;
Assess
Crystal structure of human glutaminase in apo formhomo-4-mer221-533
SO4;
Assess
Human GLS in complex with compound 3homo-4-mer222-532
36×SO4;04A;
Assess
Crystal structure of human glutaminase in complex DONhomo-4-mer221-531
ONL;
Assess
Crystal structure of human glutaminase in complex with L-glutamate and BPTEShomo-4-mer221-531
04A;GLU;SO4;
Assess
Crystal structure of human glutaminase in complex with L-glutaminehomo-4-mer221-531
GLN;SO4;
Assess
Crystal structure of human glutaminase in complex with BPTEShomo-4-mer221-531
04A;SO4;
Assess
Crystal structure of human glutaminase in complex with inhibitor 4homo-4-mer221-531
BP9;
Assess
Human GLS in complex with compound 27homo-4-mer222-532
20×SO4;R0C;
Assess
Crystal structure of human glutaminase in complex with inhibitor 2homo-4-mer221-531
BP0;SO4;
Assess
Crystal structure of human glutaminase in complex with inhibitor 3homo-4-mer221-531
BP8;SO4;
Assess
Allosteric inhibition of Kidney Isoform of Glutaminasehomo-4-mer221-531
ZBS;
Assess
Human GLS in complex with compound 18homo-4-mer222-532
20×SO4;5XX;
Assess
Near full length Kidney type Glutaminase in complex with 2,2-Dimethyl-2,3-Dihydrobenzo[a] Phenanthr…homo-2-mer136-644
HZO;
Assess
Crystal structure of glutaminase C in complex with inhibitor 2-phenyl-N-{5-[4-({5-[(phenylacetyl)am…homo-2-mer137-546
B4A;
Assess
Crystal structure of human glutaminase in complex with L-glutamatehomo-2-mer222-531
SO4;GLU;GOL;
Assess
C-terminal ankyrin repeats from human kidney-type glutaminase (KGA) - tetragonal crystal formhomo-2-mer553-645
CL;NA;
Assess
C-terminal ankyrin repeats from human kidney-type glutaminase (KGA) - monoclinic crystal formhomo-2-mer553-642
NA;
Assess
Allosteric inhibition of Kidney Isoform of Glutaminasemonomer221-531
63J;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8gwr.1.Ahomo-2-mer0.85136-644
HZO;100.00
Assess